1. Subclinical Hypertrophic Cardiomyopathy in Elite Athletes
- Author
-
Fiona Chan, Tim Lockie, Lorenzo Monserrat, James C. Moon, and Gabriella Captur
- Subjects
HCM, hypertrophic cardiomyopathy ,LGE, late gadolinium enhancement ,Case Report ,macromolecular substances ,ACTC1, actin alpha cardiac muscle 1 ,cardiac magnetic resonance ,LVH, left ventricular hypertrophy ,RV, right ventricle ,LV, left ventricle ,Clinical Case ,CMR, cardiac magnetic resonance ,cardiovascular system ,EF, ejection fraction ,genetics ,cardiovascular diseases ,Cardiology and Cardiovascular Medicine ,cardiomyopathy - Abstract
Subclinical hypertrophic cardiomyopathy (HCM) is a phenotypic entity that has emerged from the increased use of cardiovascular magnetic resonance imaging in the evaluation and family screening of patients with HCM. We describe the case of a competitive athlete with a sarcomere gene mutation and family history of HCM who was found to exhibit the subclinical HCM phenotype on cardiovascular magnetic resonance imaging in the absence of left ventricular hypertrophy. We discuss the clinical uncertainties in her management. (Level of Difficulty: Advanced.), Central Illustration
- Published
- 2022